POPULATION PHARMACOKINETIC (PK) ANALYSIS FROM FIRST-IN-HUMAN DATA FOR HDAC INHIBITOR, REC-2282, IN PATIENTS WITH SOLID TUMORS AND HEMATOLOGIC MALIGNANCIES.S. Liva,A. Mortazavi, K. Dittmar,A. Walker,C. Hofmeister,C. Coss,M. PhelpsCLINICAL PHARMACOLOGY & THERAPEUTICS（2020）引用 0|浏览2暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
